/GTG
GTG
Updated 12 July 08:33 am
$0.039
GENETIC TECHNOLOGIES LIMITED
1D0.00%
1M0.00%
1Y0.00%
Track your position in GTG
Sign in to TradeLedgr to record trades in GTG (GENETIC TECHNOLOGIES LIMITED) with broker-true precision and ATO-compliant reporting.
Recent Announcements
22 Jun 2026 12:34 AM
Termination of ADR Facility212KB
Company Administration - Other
30 Mar 2026 1:44 AM
Quarterly Activities/Appendix 4C Cash Flow Report Sept 2025537KB
Commitments Test Entity - First Quarter Activity Report
30 Mar 2026 1:44 AM
Quarterly Activities/Appendix 4C Cash Flow Report June 2025511KB
Commitments Test Entity - Fourth Quarter Activity Report
30 Mar 2026 1:32 AM
Quarterly Activities/Appendix 4C Cash Flow Report March 2025537KB
Commitments Test Entity - Third Quarter Activity Report
27 Mar 2026 1:16 AM
Initial Director's Interest Notice - Campbell Welch322KB
Initial Director's Interest Notice
Fundamentals
P/E Ratio
-99999.99x
Div Yield
0.00%
EPS
$-0.0571
Avg Vol
0
52W High
$0.040
52W Low
$0.038
Company Profile
GTG is a global leader in guideline driven genomics based tests in health, wellness and serious disease with its patented geneType polygenic based risk tests and EasyDNA brands. Our portfolio also includes pharmacogenomics, Non-Invasive Prenatal Testi
Corporate WebsiteFinancial History
2024A
$-12.0M profit
$7.7M rev
2023A
$-11.8M profit
$8.7M rev
2022A
$-7.1M profit
$6.8M rev